AbCellera Biologics (NASDAQ:ABCL) stock falls 4.6% in past week as one-year earnings and shareholder returns continue downward trend
yahoo.com
news
2022-06-05 12:21:58

As every investor would know, you don't hit a homerun every time you swing. But it's not unreasonable to try to avoid truly shocking capital losses. It must have been painful to be a AbCellera Biologics Inc. (NASDAQ:ABCL) shareholder over the last year, since the stock price plummeted 71% in that time. A loss like this is a stark reminder that portfolio diversification is important. Because AbCellera Biologics hasn't been listed for many years, the market is still learning about how the business performs.
